SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Safe & Green Holdings Corp. is a design and construction services company, which engages in the provision of code engineered cargo shipping containers. It operates through the following segments: Construction, Medical, Development, and Corporate and Support. The Construction Services segment includes the manufacturing of unit SG ECHO and other modules projects. The Medical segment consists of joint venture COVID-19 laboratory operations. The Development segment focuses on real property development. The Corporate and Support segment includes general corporate expenses such as the executive office, corporate finance, accounting, audit, tax, human resources, risk management, information technology, marketing, and legal groups, corporate overhead, and other items not allocated to any of the company's other segments. The company was founded on December 29, 1993 and is headquartered in Miami, FL.

Safe & Green Holdings Corp

Safe & Green Holdings is trending amid community excitement around a potential short squeeze, with traders actively discussing high short interest and a low float. The stock's price action and volume are fueling speculation about a significant upward move, with some comparing it to past high-flying stocks. Community members are also sharing information related to the company's new integrated energy strategy.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending due to rising memory chip prices driven by AI data center demand, with some analysts predicting substantial future growth and a new price target. Community discussions reflect bullish sentiment, but also caution about potential pullbacks after a significant year-to-date increase. Some traders point to technical indicators suggesting it may be overbought in the short-term.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending following strong earnings, with the community weighing in on the implications for the broader market and AI sector. Bullish sentiment is fueled by raised price targets and confidence in future growth, while some traders express concern about valuation and potential market corrections. Discussions also include the impact of economic data and geopolitical factors on NVIDIA's outlook.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is trending as investors assess the potential impacts of a government shutdown and subsequent SNAP benefit disruptions on the retailer's sales, with community members closely monitoring key support levels. Bullish sentiment remains due to the stock's defensive nature and potential AI integrations, while others express concerns about valuation and upcoming earnings. Additionally, discussion includes Walmart's move to sell rare sneakers and partnerships with Eli Lilly for drug distribution.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending amid discussions about potential U.S. government backing and permitting progress for deep-sea mining, spurred by recent comments from political figures and analyst ratings. Community members are weighing the potential for short squeezes and long-term growth in the critical minerals sector. Recent price action and high call option volume are fueling speculation about a potential rally.

PACS Group, Inc. is a holding company, which engages in the provision of post-acute healthcare facilities, professionals, and ancillary services. It provides senior care, assisted living, and independent living options in some of the communities. The company was founded by Jason Murray and Mark Hancock in 2013 and is headquartered in Farmington, UT.

PACS Group Inc.

PACS Group is trending following a notable pre-market surge and the release of upbeat full-year guidance, sparking considerable community discussion around potential short squeezes and analyst price targets. The stock's movement is also being discussed in the context of a possible rotation into small caps after strong performance from large-cap stocks. Community members are actively debating fair value estimates, the impact of past compliance issues, and the potential for PACS to trade at multiples comparable to its peers.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks ($PANW) is trending amid discussions around its recent earnings, where strong results were overshadowed by investor concerns about the acquisition of Chronosphere. Community chatter revolves around analyst upgrades and price target adjustments, with some traders eyeing a potential breakout while others express skepticism about the stock's valuation and near-term direction in the cybersecurity sector.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in Sarnia, Canada.

Aduro Clean Technologies Inc

Aduro Clean Technologies is trending following reports of successful pilot-scale steam-cracking of plastic-derived hydrochemolytic oil, marking a significant milestone in its commercialization pathway. The community is excited about the potential impact on the oil industry and the prospect of shaking up the sector with innovative technology. Community members are closely watching for commissioning updates from the pilot plant, with some expressing bullish sentiment.

Bath & Body Works, Inc. is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. The company was founded by Leslie Herbert Wexner in 1963 and is headquartered in Columbus, OH.

Bath & Body Works Inc

BBWI is trending due to recent earnings and forward guidance, sparking mixed reactions within the investment community. While some highlight the company's strong fundamentals and growth potential, others express concern over lowered guidance and the broader retail environment. Community discussions revolve around potential recovery, valuation, and strategic direction.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRR is trending as the community analyzes institutional ownership and AI implications from recent 13F filings, with some highlighting a large AI data center contract. Bullish sentiment is fueled by Nvidia's strong earnings, leading to discussions about a potential AI-driven rally. Community members express optimism around share buybacks and long-term growth potential, while some debate revenue forecasts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The company said the probe identified issues in its financial reporting and that it had restated its previously issued financial statements.</li><li>PACS now expects core profit for the full year to be in the range of $480 million to $490 million, above an $472.72 million expected by analysts.&nbsp;</li><li>Revenue for the full year is expected to be in the range of $5.25 billion to $5.35 billion.</li></ul>Shares of PACS Group, Inc. (PACS) jumped 53% in the pre-market session on Thursday after the company said that an audit committee had completed its independent investigation into the allegations made by short seller Hindenburg Research in its report in November 2024.The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.pacs.com/news-events/press-releases/detail/121/pacs-group-inc-reports-third-quarter-2025-results">said </a>that the recommendations by the committee have been or are being implemented. The company said that the probe identified issues within its financial reporting and restated its previously issued financial statements, including a $46.1 million reduction in the revenue reported for the three-month period ended June 30, 2024.“...today is the start of a new chapter for PACS,” said CEO Jason Murray in a call with analysts on Wednesday while reiterating efforts to build trust with stakeholders.<h2 class="st-heading-2">Outlook For The Year Ahead</h2>The company now expects core profit for the full year to be in the range of $480 million to $490 million, above the $472.72 million expected by analysts, according to data from Fiscal AI.Revenue for the full year is expected to be in the range of $5.25 billion to $5.35 billion, up from an expected $4.6 billion.<h2 class="st-heading-2">Q3 Earnings</h2>The company reported third quarter revenue of $1.34 billion, an increase of 31.0% over prior year, and above an estimated $949.48 million.Core profit for the three months was $131.5 million, above an estimated $85.90 million.PACS Group is a holding company investing in post-acute healthcare facilities. Its units operate 320 care facilities across 17 states.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around PACS stayed within the ‘extremely bullish’ territory over the past 24 hours while message volume remained at ‘extremely high’ levels. However, retail sentiment around PACS hit its highest levels this year on Thursday.<figure class="image"><img style="aspect-ratio:623/60;" src="data:image/png;base64,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" width="623" height="60" alt="PACS’s Sentiment Meter and Message Volume as of 9:15 a.m. ET on Nov. 20, 2025 | Source: Stocktwits"><figcaption>PACS’s Sentiment Meter and Message Volume as of 9:15 a.m. ET on Nov. 20, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/PACS">PACS stock</a> is up by 28% this year and down by about 2% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/tesla-urges-china-customers-to-buy-model-y-inventory-as-wait-time-for-custom-orders-stretch-into-2026/cLPAi4CRE9U">Tesla Urges China Customers To Buy Model Y Inventory As Wait Time For Custom Orders Stretch Into 2026</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, a PACS Group company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

PACS Group Stock Soars Premarket On Completion Of Audit Committee Probe, Upbeat Full-Year Guidance

The company said the committee's recommendations have been or are being implemented.

Equity

The company said the committee's recommendations have been or are being implemented.


<ul class="summary-bullets"><li>The company said that there can be no assurance that the strategic alternatives review will result in the company pursuing a transaction or any specific outcome.&nbsp;</li><li>Atkore added that no deadline or definitive timetable had been set for the completion of the strategic alternatives review.</li><li>The company also announced it will appoint Franklin Edmonds to its board as part of a cooperation agreement with Irenic Capital Management LP.&nbsp;</li></ul>Atkore Inc. (ATKR) said on Thursday that its board has expanded the scope of its previously announced review of strategic alternatives to include assets outside its core electrical infrastructure portfolio and to explore a potential sale or merger of the whole company.“As the Board conducts its expanded strategic review process, management will continue to take actions to strengthen the business, including focusing on our core electrical infrastructure business and improving our cost structure to drive profitable growth,” said Atkore’s Chairman of the Board.CEO Bill Waltz noted that, given the board’s decision to expand the strategic alternatives process, he has decided to stay on as CEO through at least the conclusion of the strategic review.<h2 class="st-heading-2">Detail On The Strategic Alternatives</h2>The company said that there can be no assurance that the strategic alternatives review will result in the company pursuing a transaction or any specific outcome. “There is no deadline or definitive timetable set for completion of the strategic alternatives review,” Atkore said.Atkore also announced it will appoint Franklin Edmonds to its board as part of a cooperation agreement with Irenic Capital Management LP. The company added that the board will form a Strategic Review Committee to oversee, evaluate, and provide advice to the full board.<h2 class="st-heading-2">What Is Retail Thinking?</h2>Retail sentiment on Atkore jumped to ‘bullish’ from ‘neutral’ territory compared to a day ago, with message volumes at ‘extremely high’ levels, according to data from Stocktwits.<a href="https://stocktwits.com/symbol/ATKR">Shares of Atkore</a> have declined by more than 20% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/why-is-gap-stock-rising-in-premarket-today/cLPAX5zRE9o">Why Is Gap Stock Rising In Premarket Today?</a>

Representative image of a trending stock chart.

Atkore Expands Review Process: CEO To Stay On As It Explores Sale Or Merger Options 

Bill Waltz noted that, given the board’s decision to expand the strategic alternatives process, he has decided to stay on as CEO.

<ul class="summary-bullets"><li>The company said that the late-stage study of Mitapivat in patients with sickle cell disease met the primary endpoint of hemoglobin response.&nbsp;</li><li>The drug also yielded positive outcomes on change from baseline in hemoglobin concentration and indirect bilirubin levels compared with placebo.&nbsp;</li><li>While Mitapivat also showed a reduction in the primary endpoint of annualized rate of sickle cell pain crises compared to placebo, this trend did not achieve statistical significance, the company noted.</li></ul>Shares of Agios Pharmaceuticals, Inc. (AGIO) slumped 48% on Wednesday after the company reported mixed results from its drug trial in sickle cell disease.Sickle cell disease is an inherited blood disorder where red blood cells become rigid, sickle-shaped, and unable to flow easily through blood vessels, causing pain and organ damage. The condition leads to complications like painful episodes or crises, anemia, infections, stroke, and damage to organs.<h2 class="st-heading-2">What Did The Study Show?</h2>The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/11/19/3190791/31990/en/Agios-Announces-Topline-Results-from-RISE-UP-Phase-3-Trial-of-Mitapivat-in-Sickle-Cell-Disease.html">said</a> that the late-stage study of Mitapivat in patients aged 16 years and older with sickle cell disease met the primary endpoint of hemoglobin response, with the drug demonstrating a statistically significant improvement compared to placebo. Hemoglobin response is defined as an increase from baseline in average hemoglobin by more than or equal to 1.0 g/dL.The drug also showed positive effects on changes from baseline in hemoglobin concentration and indirect bilirubin levels compared with placebo.While Mitapivat also showed a reduction in the primary endpoint of annualized rate of sickle cell pain crises (SCPCs) or acute pain needing medical contact compared to placebo, this trend did not achieve statistical significance, the company noted. Further, there were no improvements from baseline on fatigue scores among patients, the company noted.The firm now expects to share the comprehensive results from the clinical program with the FDA in the first quarter of 2026 and seek potential U.S. regulatory approval.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/AGIO">AGIO stock</a> jumped from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘high’ to ‘extremely high’ levels.AGIO stock is down by 28% this year and by 57% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/kzia-stock-soars-after-company-stage-iv-cancer-patients-shows-initial-complete-remission-on-its-drug-combination/cLPoQdMREBN">KZIA Stock Soars After Stage IV Cancer Patient Shows Initial Complete Remission On Its Drug Combination</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, the Agios Pharmaceuticals logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

AGIO Stock Cracks After Sickle-Cell Disease Drug Delivers Mixed Results In Late-Stage Trial 

 Sickle cell disease is an inherited blood disorder where red blood cells become rigid, sickle-shaped, and unable to flow easily through blood vessels, causing pain and organ damage.

<ul class="summary-bullets"><li>Joby noted that the sandbox will serve as a base for evaluating potential air taxi operations in the region.</li><li>Saudi Arabia joins the U.S., the U.K., Japan, South Korea and the UAE as another key launch market for Joby's air taxi service.</li><li>In September, the company announced a long-term collaboration with the Ras Al Khaimah Transport Authority and Skyports Infrastructure to launch a passenger air taxi service network in the Emirate of Ras Al Khaimah by 2027.</li></ul>Joby Aviation (JOBY) said on Wednesday it has signed a memorandum of understanding with Red Sea Global and The Helicopter Company that includes plans for Joby to complete pre-commercial evaluation flights of its electric air taxi in Saudi Arabia in the first half of 2026.The company said that under the agreement, Joby will work together with Red Sea Global, the developer behind regenerative tourism destinations The Red Sea and AMAALA, and The Helicopter Company, a Public Investment Fund company and Saudi Arabia’s commercial helicopter operator, to establish a "sandbox" for pre-commercial operations.Joby noted that the sandbox will serve as a base for evaluating potential air taxi operations in the region, with Joby conducting representative flights that include charging, airspace integration, and ground communications, similar to the flights it completed in the UAE earlier this year.Shares of Joby, which develops electric air taxis for commercial passenger service, were up nearly 2% in premarket trading.<h2 class="st-heading-2">Use Of FAA Certification</h2>The new partnership announced on Wednesday comes following Joby's announcement last week that it would collaborate with the General Authority of Civil Aviation (GACA) to support the development of the Kingdom's air taxi regulatory framework, using Federal Aviation Administration (FAA) certification standards as a foundation.According to a new memorandum of understanding with GACA, Joby will use FAA certification standards as a foundation to create a streamlined approval process for Joby’s aircraft in Saudi Arabia. Saudi Arabia joins the U.S., the U.K., Japan, South Korea and the UAE as another key launch market for Joby's air taxi service.<h2 class="st-heading-2">Joby’s Expansion In The Middle East</h2>In September, the company announced a long-term collaboration with the Ras Al Khaimah Transport Authority and Skyports Infrastructure to launch a passenger air taxi service network in the Emirate of Ras Al Khaimah by 2027.Joby had noted that as part of a six-year exclusive agreement, the company is also planning to start air taxi operations in Dubai in 2026. Joby, in November, said that the company signed a letter of intent to sell aircraft and services valued at up to $250 million to Alatau Advance Air Group dedicated to introducing air taxis to Kazakhstan.Retail sentiment on Joby remained unchanged in the ‘bearish’ territory, with message volumes at ‘low’ levels, according to data from Stocktwits.<a href="https://stocktwits.com/symbol/JOBY">Shares of Joby</a> have gained nearly 125% in the last 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/nokia-restructures-operations-into-network-and-mobile-infrastructure-segments-as-company-focuses-on-ai/cLPoIMyREBT">Nokia Restructures Operations Into Network And Mobile Infrastructure Segments As Company Focuses On AI</a>

ANA Holdings and Joby Aviation show a public demonstration flight of the Joby N5.42JX flying car at the World Expo 2025 Osaka on October 13, 2025 in Osaka, Japan.

Joby Aviation To Launch Electric Air Taxi Test Flights In Saudi Arabia

The company said that under the agreement, Joby will work together with Red Sea Global and The Helicopter Company to establish a "sandbox" for pre-commercial operations.

<ul class="summary-bullets"><li>In the initial phase of the agreement, Archer Aviation will work with The Helicopter Company as well as RSG to help build the foundational framework for its planned eVTOL operations in Saudi Arabia.</li><li>After the testing program, the parties involved will review the results and consider further initiatives for large-scale introduction of eVTOL services, they said.</li></ul> Archer Aviation Inc. (ACHR) has inked a deal with The Helicopter Company to bring their Midnight air taxi to the Kingdom of Saudi Arabia in partnership with Red Sea Global (RSG), the eVTOL maker said on Wednesday.The partnership <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.investors.archer.com/news/news-details/2025/PIFs-The-Helicopter-Company-Archer-Aviation-and-Red-Sea-Global-Partner-to-Launch-eVTOL-Air-Mobility-in-Saudi-Arabia/default.aspx">will focus</a> on the development, testing, and potential integration of Archer’s eVTOL aircraft into RSG’s operations as one of the first deployments of eVTOL aircraft in the Kingdom of Saudi Arabia.<h2 class="st-heading-2">How Will The Partnership Work?</h2>While The Helicopter Company is a Saudi Public Investment Fund company and commercial helicopter operator, Red Sea Global (RSG), is the real estate developer behind regenerative tourism destinations The Red Sea and AMAALA.In the initial phase of the agreement, Archer Aviation will work with The Helicopter Company as well as RSG to help build the foundational framework for their planned eVTOL operations in Saudi Arabia, including the establishment of an environment to conduct test flights with Archer’s Midnight eVTOL under real-world conditions.As the partnership progresses, RSG will lead testing with Archer’s Midnight aircraft to evaluate the potential to integrate eVTOL aircraft into the company’s future operations.&nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2><a href="https://stocktwits.com/symbol/ACHR">ACHR shares</a> rose 1% in the pre-market session at the time of writing. On Stocktwits, retail sentiment around ACHR jumped from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.ACHR stock is down by 22% this year and up by about 48% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/alkermes-to-acquire-avadel-for-up-to-2.37-billion-after-lundbeck-proposal/cLPoIyoREB2">Race For Avadel Heats Up: Alkermes Raises Offer To Secure $2.37B Deal After Lundbeck Challenge</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, the Archer Aviation logo is displayed on a smartphone screen. (Photo by Cheng Xin/Getty Images)

Archer Aviation Lands Partnership To Deploy Air Taxi In Saudi Arabia

The partnership will focus on the development, testing, and potential integration of Archer’s eVTOL aircraft into RSG’s operations. 

In this photo illustration, the Scholar Rock Holding logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Why Did Scholar Rock Soar 26% Today?

The company is planning to reapply for approval of a muscle atrophy therapy in the coming year. 

<ul class="summary-bullets"><li>The report stated that private equity firm Leonard Green had previously acquired a minority stake in Topgolf.</li><li>Last year, Topgolf Callaway Brands announced its intention to pursue the separation of its business into two independent companies.</li><li>The company had then said that it expects to effect the separation through a spin-off of the Topgolf business.</li></ul>Topgolf Callaway Brands (MODG) stock rose nearly 5% after the company reportedly entered into discussions with private-equity firm Leonard Green to sell its Topgolf unit.According to a report by The Wall Street Journal, citing people familiar with the matter, the deal would value Topgolf at about $1 billion. The report added that Leonard Green had previously acquired a minor stake in Topgolf.<h2 class="st-heading-2">Topgolf Callaway Brands Separation</h2>This report comes more than a year after Topgolf Callaway Brands announced its intention to separate its business into two independent companies: Callaway, a golf equipment company with an activewear business, and Topgolf, a golf entertainment business.The company had then said that it expects to effect the separation through a spin-off of the Topgolf business. While the firm had stated that it expects a spin-off of Topgolf into a stand-alone public company to be the most likely separation path, it also noted that it would continue to evaluate other options for separation.<h2 class="st-heading-2">How Did Retail Users React?</h2>Retail sentiment on <a href="https://stocktwits.com/symbol/MODG">Topgolf Callaway Brands</a> dipped to ‘bullish’ from ‘extremely bullish’ territory compared to a day ago, with message volumes at ‘high’ levels, according to data from Stocktwits.Shares of the company have gained nearly 45% this year and increased by 33% over the last 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/doug-mcmillon-to-retire-from-walmart-in-january-john-furner-to-succeed/cLPQO3ZRE4f">Doug McMillon To Retire From Walmart In January, John Furner To Succeed As CEO</a>

Topgolf Callaway Brands Jumps 5% After Report Says Talks Are On To Sell Topgolf Unit

According to a report by The Wall Street Journal, citing people familiar with the matter, the deal would value Topgolf at about $1 billion.

<ul class="summary-bullets"><li>Under the deal, Merck will buy Cidara for $221.50 per share in cash through a unit.</li><li>The purchase price represents a premium of about 109% from CDTX’s closing price on Thursday.</li></ul>Merck (MRK) said on Friday that it has entered into a definitive agreement to acquire Cidara Therapeutics (CDTX) for about $9.2 billion.Under the deal, Merck will buy Cidara for $221.50 per share in cash through a unit. The purchase price represents a premium of about 109% from CDTX’s closing price on Thursday. The <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.merck.com/news/merck-to-acquire-cidara-therapeutics-inc-diversifying-its-portfolio-to-include-late-phase-antiviral-agent/">transaction</a> is expected to close in the first quarter of 2026, subject to the satisfaction of certain conditions.<h2 class="st-heading-2">What Does The Deal Bring For Merck?</h2>The takeover marks Merck’s latest move to fortify its drug portfolio before Keytruda, its $25 billion-per-year cancer therapy, loses patent protection in 2028. The company agreed in July to buy respiratory drug developer Verona Pharma for $10 billion as part of a broader effort to maintain revenue momentum.With the new deal, Merck would gain access to Cidara’s lead candidate CD388 designed to prevent influenza infection in individuals at higher risk of influenza complications. CD388 has been granted a breakthrough designation by the U.S. Food and Drug Administration, which could accelerate regulatory approval.The treatment is currently being evaluated in a late-stage trial among both adult and adolescent participants who are at higher risk of developing complications from influenza. The trial is expected to enroll 6000 participants by December, the company said earlier this month.“This acquisition expands and complements our respiratory portfolio and pipeline. Influenza continues to pose a significant global health threat, causing widespread illness, morbidity and death each year especially in older adults and immunocompromised individuals, such as those with cancer and chronic diseases,” said Dr. Dean Y. Li, President, Merck Research Laboratories.The deal has been approved by the board of directors of both companies, Merck said.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2><a href="https://stocktwits.com/symbol/CDTX">CDTX shares</a> jumped 105% in the premarket session at the time of writing, while <a href="https://stocktwits.com/symbol/MRK">MRK shares</a> fell over 1%. On Stocktwits, retail sentiment around CDTX jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘normal’ to ‘extremely high’ levels.CDTX stock has nearly quadrupled in value this year, while MRK shares have fallen 7%.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/avxl-shares-slump-pre-market-after-ema-committee-fails-to-recommend-approval-for-alzheimers-drug/cLPQ7tkRE4E">AVXL Shares Slump Pre-Market After EMA Committee Fails To Recommend Approval For Alzheimer’s Drug</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, the Cidara Therapeutics logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Merck To Buy Cidara In $9.2B Deal To Strengthen Antiviral Portfolio

With the new deal, Merck would gain access to CD388, currently in late-stage development, and designed to prevent influenza infection in individuals at higher risk of influenza complications. 

<ul class="summary-bullets"><li>CHMP provides recommendations to the EMA on human medicines, which the agency uses to approve or reject a drug.</li><li>However, the drug didn’t feature on the list of medicines for which applications were withdrawn following a meeting with the committee.&nbsp;</li><li>Anavex confirmed on Friday that it was informed by the CHMP of a negative trend vote on its application for Blarcamesine following its oral explanation.</li></ul>Shares of Anavex Life Sciences (AVXL) slumped 45% in the premarket session on Friday after a European Medicines Agency (EMA) committee did not recommend a much-awaited approval for the company’s Alzheimer’s drug Blarcamesine.Retail investors were looking forward to the Committee for Medicinal Products for Human Use’s opinion on the drug after it placed Blarcamesine on its agenda for oral explanations and regulatory review during the session scheduled from Nov. 10 to Nov.13, with the oral explanation held behind closed doors on Nov. 11.<h2 class="st-heading-2">CHMP Avoids Recommendation For Blarcamesine</h2>The CHMP <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-10-13-november-2025">released</a> its meeting highlights on Friday and recommended approval for ten new medicines, but Blarcamesine did not feature on the list. CHMP provides recommendations to the EMA on human medicines, which the agency uses to approve or reject a drug. The lack of a positive recommendation dampens chances for an EMA approval for the drug.However, the drug also didn’t feature on the list of medicines for which applications were withdrawn following a meeting with the committee.Anavex <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/11/14/3188222/29248/en/Anavex-Life-Sciences-Provides-Regulatory-Update-on-Blarcamesine-for-Early-Alzheimer-s-Disease.html">confirmed</a> on Friday that it was informed by the CHMP of a negative trend vote on its application for Blarcamesine following its oral explanation. The committee is expected to adopt a formal opinion on the application at its December meeting, the company said, while adding that it intends to request a re-examination of the committee’s opinion.Anavex submitted an application to the EMA for Blarcamesine in November 2024 based on data from a Phase 2b/3 trial, and the agency subsequently accepted it in December. If the application is approved, it would allow Blarcamesine to be marketed in all EU member states.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around<a href="https://stocktwits.com/symbol/AVXL"> AVXL stock </a>stayed within the ‘extremely bullish’ territory over the past 24 hours, while message volume stayed at ‘extremely high’ levels.AVXL stock is down 47% this year and by 29% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/avadel-gets-acquisition-proposal-from-lundbeck-weeks-after-inking-agreement-with-alkermes/cLPQetHRE4T">Avadel Gets Acquisition Proposal From Lundbeck Weeks After Inking Agreement With Alkermes</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

AVXL Shares Slump Pre-Market After EMA Committee Fails To Recommend Approval For Alzheimer’s Drug

The CHMP released its meeting highlights on Friday and recommended approval for ten new medicines, but Blarcamesine was not included in the list.

<ul class="summary-bullets"><li>For the third quarter, the company reported net revenue of $104.3 million, up from the $11.5 million reported in the corresponding quarter of 2024.</li><li>The growth in revenue was driven by higher-than-expected utilization of DefenCath by outpatient dialysis customers, the company said.</li><li>Adjusted earnings before interest, taxes, depreciation and amortization in Q3 came in at $71.9 million, above an expected $40.65 million.</li></ul>&nbsp;Shares of CorMedix Inc. (CRMD) soared 9% in the pre-market session on Wednesday after the company raised its full-year revenue guidance on the heels of upbeat Q3 earnings.The company now <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/11/12/3186117/0/en/CorMedix-Inc-Reports-Third-Quarter-2025-Financial-Results-and-Updates-FY-2025-Guidance.html">expects</a> pro forma net revenue for the full year in a range of $390 million to $410 million, up from its September guidance of $325 to $350 million and higher than a Wall Street estimate of $283.66 million. &nbsp;Fully synergized pro forma adjusted earnings before interest, taxes, depreciation and amortization for 2025 are now expected in a range of $220 – $240 million, higher that the previously estimated $165 million – $185 million.<h2 class="st-heading-2">Q3 Numbers Beat Wall Street Expectations</h2>For the third quarter, the company reported net revenue of $104.3 million, up from the $11.5 million reported in the corresponding quarter of 2024, and above an analyst estimate of $86.02 million.The growth in revenue was driven by higher-than-expected utilization of DefenCath by outpatient dialysis customers, the company said. DefenCath is an FDA-approved catheter lock solution used to reduce catheter-related bloodstream infections in adult patients undergoing chronic hemodialysis through a central venous catheter. It contributed about 85% of the company’s net revenue in the quarter, the company noted.Adjusted earnings before interest, taxes, depreciation and amortization in Q3 came in at $71.9 million, above an expected $40.65&nbsp;&nbsp;&nbsp;&nbsp; million.Diluted earnings per share in the quarter was at $1.26, above an expected $0.63.<h2 class="st-heading-2">Melinta Therapeutics Acquisition</h2>Cormedix completed the acquisition of Melinta for an upfront consideration of $300 million on August 29. The company now expects synergy capture of approximately $30 million, of the total estimated $35 – $45 million, on an annual run-rate basis before the end of 2025.Sales of Melinta’s portfolio of anti-infective products also aided Cormedix’s revenue in the third quarter.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/CRMD">CRMD stock</a> jumped from ‘bearish’ to ‘neutral’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘normal’ levels.CRMD stock is up by 38% this year but down by 4% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/general-motors-races-to-decouple-supply-chain-from-china-report/cLPIHl2RE5r">General Motors Races To Decouple Supply Chain From China: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance 

The company now expects pro forma net revenue for the full year in a range of $390 million to $410 million, higher than a Wall Street estimate of $283.66 million.  

IWMW
iShares Russell 2000 BuyWrite ETF

Feed

News

Sentiment

Fundamentals

Info

Latest IWMW News

IWMWiShares Russell 2000 BuyWrite ETF